Total Payments
$6,853
2024 Payments
$355.25
Companies
42
Transactions
397
Medicare Patients
8,242
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$6,612 (96.5%)
Other$207.44 (3.0%)
Education$33.06 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,612 | 391 | 96.5% |
| Debt forgiveness | $182.44 | 1 | 2.7% |
| Education | $33.06 | 4 | 0.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $25.00 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $810.76 | 48 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $708.06 | 68 | $0 (2023) |
| Lilly USA, LLC | $595.12 | 34 | $0 (2024) |
| Novo Nordisk Inc | $588.45 | 37 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $535.84 | 33 | $0 (2024) |
| PFIZER INC. | $488.07 | 30 | $0 (2022) |
| Amgen Inc. | $469.29 | 31 | $0 (2024) |
| GlaxoSmithKline, LLC. | $302.75 | 13 | $0 (2023) |
| Baxter Healthcare | $182.44 | 1 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $181.31 | 11 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $355.25 | 19 | Novo Nordisk Inc ($84.31) |
| 2023 | $824.95 | 38 | Bayer Healthcare Pharmaceuticals Inc. ($181.85) |
| 2022 | $781.14 | 33 | Baxter Healthcare ($182.44) |
| 2021 | $917.12 | 49 | Bayer HealthCare Pharmaceuticals Inc. ($167.55) |
| 2020 | $961.95 | 59 | AstraZeneca Pharmaceuticals LP ($184.45) |
| 2019 | $613.87 | 39 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($80.15) |
| 2018 | $969.81 | 64 | Amgen Inc. ($148.46) |
| 2017 | $1,428 | 96 | Novo Nordisk Inc ($245.97) |
All Payment Transactions
397 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/15/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Inflammation | ||||||
| 09/23/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Diabetes | ||||||
| 09/13/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Oncology | ||||||
| 08/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Respiratory | ||||||
| 08/06/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: VACCINE | ||||||
| 08/02/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Diabetes | ||||||
| 07/23/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Diabetes | ||||||
| 06/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Inflammation | ||||||
| 06/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Cardio-renal | ||||||
| 05/22/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Diabetes | ||||||
| 05/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Cardio-renal | ||||||
| 04/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/15/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: Diabetes | ||||||
| 02/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $19.82 | General |
| 02/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Cardio-renal | ||||||
| 02/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Cardiology | ||||||
| 02/01/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Diabetes | ||||||
| 12/05/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $5.80 | General |
| Category: Cardio-renal | ||||||
| 11/09/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Inflammation | ||||||
| 11/02/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $9.56 | General |
| Category: Cardio-renal | ||||||
| 10/13/2023 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $116.00 | General |
| Category: NEUROLOGY | ||||||
| 10/12/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Neuroscience | ||||||
| 10/12/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $7.05 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 2,137 | 4,408 | $476,988 | $267,486 |
| 2022 | 32 | 2,002 | 4,560 | $470,289 | $248,877 |
| 2021 | 29 | 2,007 | 5,165 | $533,322 | $289,199 |
| 2020 | 32 | 2,096 | 4,942 | $428,245 | $257,643 |
Total Patients
8,242
Total Services
19,075
Medicare Billing
$1.1M
Procedure Codes
123
All Medicare Procedures & Services
123 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 325 | 960 | $119,965 | $63,788 | 53.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 117 | 682 | $85,250 | $42,810 | 50.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 228 | 418 | $68,955 | $40,628 | 58.9% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 29 | 166 | $28,750 | $19,600 | 68.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 92 | 122 | $33,550 | $16,540 | 49.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 120 | 120 | $16,800 | $15,274 | 90.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 75 | 156 | $23,400 | $14,422 | 61.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 123 | 191 | $23,875 | $12,176 | 51.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 98 | 98 | $9,310 | $6,382 | 68.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 24 | 27 | $8,775 | $5,862 | 66.8% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 24 | 29 | $6,525 | $4,627 | 70.9% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 22 | 25 | $6,250 | $3,617 | 57.9% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 104 | 104 | $3,640 | $2,697 | 74.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 66 | 256 | $7,680 | $2,611 | 34.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 51 | 60 | $4,500 | $2,327 | 51.7% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 124 | 124 | $3,720 | $2,221 | 59.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 120 | 120 | $3,600 | $2,149 | 59.7% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 30 | 49 | $3,185 | $1,521 | 47.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $2,700 | $1,517 | 56.2% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 55 | 55 | $1,925 | $1,409 | 73.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 16 | 17 | $1,530 | $1,211 | 79.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 54 | 69 | $3,450 | $1,180 | 34.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $2,625 | $1,158 | 44.1% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 26 | 33 | $660.00 | $486.09 | 73.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 36 | 38 | $2,280 | $422.54 | 18.5% |
About Dr. Azzam Adhal, MD
Dr. Azzam Adhal, MD is a Internal Medicine healthcare provider based in Panama City, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1295714129.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Azzam Adhal, MD has received a total of $6,853 in payments from pharmaceutical and medical device companies, with $355.25 received in 2024. These payments were reported across 397 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($6,612).
As a Medicare-enrolled provider, Adhal has provided services to 8,242 Medicare beneficiaries, totaling 19,075 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 123 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Panama City, FL
- Active Since 01/10/2006
- Last Updated 11/15/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1295714129
Products in Payments
- FARXIGA (Drug) $577.85
- Kerendia (Drug) $535.84
- XARELTO (Drug) $496.61
- TRULICITY (Drug) $258.34
- ELIQUIS (Drug) $241.63
- CHANTIX (Drug) $226.67
- MOUNJARO (Drug) $212.41
- SPRAVATO (Drug) $202.47
- XIFAXAN (Drug) $199.95
- Repatha (Biological) $188.86
- Ozempic (Drug) $175.69
- Victoza (Drug) $161.48
- NUEDEXTA (Drug) $159.45
- CoreValve Evolut (Device) $143.78
- Prolia (Biological) $140.49
- TRELEGY ELLIPTA (Drug) $131.21
- ENTRESTO (Drug) $119.82
- VYVGART (Drug) $115.20
- SYMBICORT (Drug) $111.97
- GOCOVRI (Drug) $91.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Panama City
Dr. Saeed Khaja, Do, DO
Internal Medicine — Payments: $50,888
Internal Medicine $50,888
Dr. Ajay Mhatre, M.d, M.D
Internal Medicine — Payments: $50,085
Internal Medicine $50,085
Dr. Don Davis, Md, MD
Internal Medicine — Payments: $33,275
Internal Medicine $33,275
Dr. Marwan Obid, M.d, M.D
Internal Medicine — Payments: $28,146
Internal Medicine $28,146
Dr. Lindsey Weintritt-Davis, M.d, M.D
Internal Medicine — Payments: $9,733
Internal Medicine $9,733
Rafael Ching Companioni, M.d, M.D
Internal Medicine — Payments: $6,990
Internal Medicine $6,990